English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Astellas Pharma Us, Inc.
Carol Ostrow
| Dec 3, 2017
Astellas will present AML findings at American Society of Hematology conference
Carrie Bradon
| Dec 1, 2017
Astellas study shows women with overactive bladder symptoms use unconventional methods
Carrie Bradon
| Nov 25, 2017
Astellas Oncology names C3 Prize winners
Marian Johns
| Nov 19, 2017
Astellas receives perfect score on Corporate Equality Index for fourth consecutive year
Marian Johns
| Oct 22, 2017
FDA grants fast-track status to Astellas' acute myeloid leukemia drug
Marian Johns
| Oct 19, 2017
Astellas Pharma, Seattle Genetics begin clinical trial for bladder cancer treatment
Robert Hadley
| Jul 7, 2017
Astellas says gilteritinib may be long-sought treatment in certain acute myeloid leukemia cases
Robert Hadley
| Jun 22, 2017
Phase 3 trial of Pfizer’s prostate cancer drug could yield results two years early
Trending
Patient Daily
| Aug 18, 2025
Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
+
Pharmaceuticals
Patient Daily
| Aug 18, 2025
Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
+
Pharmaceuticals
Patient Daily
| Aug 21, 2025
PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program
Patient Daily
| Aug 21, 2025
SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
1
2
»
Last »